Precigen Inc

Precigen Inc is an American biotechnology that focuses on developing precision-engineered gene and cell therapies. Its primary aim is to advance innovative biological solutions for various unmet medical needs. The company operates globally, aiming to impact patients and healthcare systems worldwide. Operating within the biotechnology sector, Precigen Inc leverages advanced genetic engineering platforms. Its focus is on creating highly targeted and effective treatments across different therapeutic areas, including oncology and autoimmune disorders. The intended outcome is to deliver transformative medicines. Keep up to date on the latest share price changes by adding PGEN stock to your eToro watchlist. This content was generated by artificial intelligence. We cannot guarantee the accuracy, completeness, or timeliness of the information provided.